POLIDOCANOL WITH SINGLE MOLECULAR WEIGHT, AND USE THEREOF

Title:

POLIDOCANOL WITH SINGLE MOLECULAR WEIGHT, AND USE THEREOF

Document Type and Number:

WIPO Patent Application WO/2023/227069

Kind Code:

A1

Abstract:

The present invention relates to use of polidocanol with a single molecular weight in the preparation of a drug for treating disease. The polidocanol can serve as a curing agent and/or a hemostatic agent for treatment. The polidocanol with a single molecular weight is prepared by the following preparation method: reacting polyethylene glycol with a single molecular weight with 1-halododecane, and performing separation and purification to obtain the polidocanol with a single molecular weight. The propolidocanol of the present invention is produced by a stable process, is of controllable quality, is good in efficacy, and causes few toxic and side effects.

More Like This:

JP2012149075	METHOD OF SYNTHESIZING OXIDIZED PHOSPHOLIPID AND PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF ATHEROSCLEROSIS
WO/2004/035656	PERFLUOROPOLYETHER DERIVATIVES
WO/2008/124055	NON-SPECIFIC DELAYED-TYPE HYPERSENSITIVITY RESPONSE TO TREAT HERPES SIMPLEX VIRUS INFECTION

Inventors:

WANG QINGBIN (CN)
TANG JIAZE (CN)
LIU BIAO (CN)
YU XIAOPENG (CN)
ZHENG XICHUN (CN)
LI QIUFEN (CN)
WANG JIE (CN)
GUO JUN (CN)
ZHAO XUAN (CN)

Application Number:

PCT/CN2023/096332

Publication Date:

November 30, 2023

Filing Date:

May 25, 2023

Export Citation:

Click for automatic bibliography generation Help

Assignee:

JENKEM TECH CO LTD BEIJING (CN)

International Classes:

A61K31/08; A61P7/04; A61P9/14; C07C41/09; C07C43/13; C08G59/00

Domestic Patent References:

WO2002053145A1

2002-07-11

Foreign References:

CN106316802A	2017-01-11
CN110156827A	2019-08-23
CN112654562A	2021-04-13
US20140243391A1	2014-08-28
JP2012058477A	2012-03-22

Other References:

WU MING-RUI, OUYANG SHAN-BEI, LIN LIANG, REN JUN: "Experimental Study on the Hemostasia Effect of Lauromacrogol in Skin Soft Tissue Expansion Surgery", CHINESE JOURNAL OF AESTHETIC MEDICINE, vol. 21, no. 2, 20 February 2012 (2012-02-20), pages 184 - 185, XP009550851, ISSN: 1008-6455, DOI: 10.15909/j.cnki.cn61-1347/r.2012.02.024

Attorney, Agent or Firm:

BEIJING LINKTEC IP LAW FIRM (SPECIAL GENERAL PARTNERSHIP) (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: A NEW SITE FOR TRANSPLANTATION

Next Patent: DOUBLE-STRANDED RIBONUCLEIC ACID FOR INHIBITING C3 GENE EXPRESSION AND MODIFIER, CONJUGATE, AND USE ...